Single chain antibody against the common epitope of mutant p53 restores wild-type activity to mutant p53 protein

被引:4
|
作者
Orgad, S [1 ]
Goldfinger, N
Cohen, G
Rotter, V
Solomon, B
机构
[1] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel
[2] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel
关键词
p53; p53-R175H mutant; single chain Fv fragment; activity restoration;
D O I
10.1016/j.febslet.2005.09.031
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Here, we describe the biological activity of ME1, a mouse single chain Fv fragment (scFv) against the common epitope of mutant p53, which is efficiently expressed in mammalian cells. We found that in vivo interaction of the conformational p53 mutant R175H protein with the scFv resulted in the acquisition of wild-type p53 characteristics, manifested in trans-activation of p21, as well as induction of apoptosis. Moreover, antibody binding leads to abrogation of the mutant p53 mediated "gain of function" as estimated by downregulation of EGR-1, a transcriptional target of mutant p53. These findings suggest that the scFv restores wild-type properties to mutant p53. (c) 2005 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
引用
收藏
页码:5609 / 5615
页数:7
相关论文
共 50 条
  • [1] COTRANSLATION OF ACTIVATED MUTANT P53 WITH WILD-TYPE DRIVES THE WILD-TYPE P53 PROTEIN INTO THE MUTANT CONFORMATION
    MILNER, J
    MEDCALF, EA
    CELL, 1991, 65 (05) : 765 - 774
  • [2] Activities of wild-type and mutant p53
    Vousden, Karen H.
    CANCER RESEARCH, 2013, 73
  • [3] TUMOR SUPPRESSOR P53 - ANALYSIS OF WILD-TYPE AND MUTANT P53 COMPLEXES
    MILNER, J
    MEDCALF, EA
    COOK, AC
    MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (01) : 12 - 19
  • [4] Chaperoning of Mutant p53 Protein by Wild-type p53 Protein Causes Hypoxic Tumor Regression
    Gogna, Rajan
    Madan, Esha
    Kuppusamy, Periannan
    Pati, Uttam
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (04) : 2907 - 2914
  • [5] ADP-ribosylation of p53 tumor suppressor protein: Mutant but not wild-type p53 is modified
    WesierskaGadek, J
    BugajskaSchretter, A
    Cerni, C
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1996, 62 (01) : 90 - 101
  • [6] Mutant p53: Gain-of-function oncoproteins and wild-type p53 inactivators
    Roemer, K
    BIOLOGICAL CHEMISTRY, 1999, 380 (7-8) : 879 - 887
  • [7] DNA binding distinguishes wild-type and mutant p53 activity
    Ray, Debolina
    Gal, Susannah
    CANCER RESEARCH, 2010, 70
  • [8] Inhibition of mutant p53 phosphorylation at serine 15 or serine 315 partially restores the function of wild-type p53
    Sugikawa, E
    Yazaki, N
    Tsunoda, S
    Nakanishi, N
    Ohashi, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (02) : 256 - 263
  • [9] Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein
    A Vinyals
    M A Peinado
    M Gonzalez-Garrigues
    M Monzó
    R D Bonfil
    A Fabra
    Gene Therapy, 1999, 6 : 22 - 33
  • [10] Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein
    Vinyals, A
    Peinado, MA
    Gonzalez-Garrigues, M
    Monzó, M
    Bonfil, RD
    Fabra, A
    GENE THERAPY, 1999, 6 (01) : 22 - 33